{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:01:16Z","timestamp":1793826076273,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Hunan Provincial Health Commission","award":["A202309026329"],"award-info":[{"award-number":["A202309026329"]}]},{"name":"Natural Science Foundation of Hunan Provincial Health Commission","award":["A202309026329"],"award-info":[{"award-number":["A202309026329"]}]},{"name":"Natural Science Foundation of Hunan Provincial Health Commission","award":["A202309026329"],"award-info":[{"award-number":["A202309026329"]}]},{"name":"Natural Science Foundation of Hunan Provincial Health Commission","award":["A202309026329"],"award-info":[{"award-number":["A202309026329"]}]},{"name":"Natural Science Foundation of Hunan Provincial Health Commission","award":["A202309026329"],"award-info":[{"award-number":["A202309026329"]}]},{"name":"Natural Science Foundation of Hunan Provincial Health Commission","award":["A202309026329"],"award-info":[{"award-number":["A202309026329"]}]},{"name":"Natural Science Foundation of Hunan Provincial Health Commission","award":["A202309026329"],"award-info":[{"award-number":["A202309026329"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03485-w","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T07:50:44Z","timestamp":1749455444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sonodynamic therapy-boosted biomimetic nanoplatform targets ferroptosis and CD47 as vulnerabilities for cancer immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Haiqin","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"10","key":"3485_CR1","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1021\/acsnano.2c08240","volume":"17","author":"JQ Luo","year":"2023","unstructured":"Luo JQ, Liu R, Chen FM, Zhang JY, Zheng SJ, Shao D, Du JZ. Nanoparticle-mediated CD47-SIRPalpha blockade and calreticulin exposure for improved cancer chemo-immunotherapy. ACS Nano. 2023;17(10):8966\u201379. https:\/\/doi.org\/10.1021\/acsnano.2c08240. (From NLM Medline).","journal-title":"ACS Nano"},{"key":"3485_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119110","volume":"271","author":"N Hashemzadeh","year":"2021","unstructured":"Hashemzadeh N, Dolatkhah M, Adibkia K, Aghanejad A, Barzegar-Jalali M, Omidi Y, Barar J. Recent advances in breast cancer immunotherapy: the promising impact of nanomedicines. Life Sci. 2021;271: 119110. https:\/\/doi.org\/10.1016\/j.lfs.2021.119110. (From NLM Medline).","journal-title":"Life Sci"},{"issue":"6","key":"3485_CR3","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1021\/acs.accounts.9b00148","volume":"52","author":"Y Shi","year":"2019","unstructured":"Shi Y, Lammers T. Combining nanomedicine and immunotherapy. Acc Chem Res. 2019;52(6):1543\u201354. https:\/\/doi.org\/10.1021\/acs.accounts.9b00148. (From NLM Medline).","journal-title":"Acc Chem Res"},{"issue":"1","key":"3485_CR4","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1038\/s41467-022-32160-z","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Tian S, Huang L, Li Y, Lu Y, Li H, Chen G, Meng F, Liu GL, Yang X, et al. Reactive oxygen species-responsive and Raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment. Nat Commun. 2022;13(1):4553. https:\/\/doi.org\/10.1038\/s41467-022-32160-z. (From NLM Medline).","journal-title":"Nat Commun"},{"issue":"17","key":"3485_CR5","doi-asserted-by":"publisher","first-page":"2000411","DOI":"10.1002\/advs.202000411","volume":"7","author":"Q Chen","year":"2020","unstructured":"Chen Q, He Y, Wang Y, Li C, Zhang Y, Guo Q, Zhang Y, Chu Y, Liu P, Chen H, et al. Penetrable nanoplatform for \u201ccold\u201d tumor immune microenvironment reeducation. Adv Sci (Weinh). 2020;7(17):2000411. https:\/\/doi.org\/10.1002\/advs.202000411. (From NLM PubMed-not-MEDLINE).","journal-title":"Adv Sci (Weinh)"},{"key":"3485_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53010-0","author":"Y Guo","year":"2024","unstructured":"Guo Y, Li Y, Zhang M, Ma R, Wang Y, Weng X, Zhang J, Zhang Z, Chen X, Yang W. Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-53010-0.","journal-title":"Nat Commun"},{"issue":"2","key":"3485_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1. (From NLM Medline).","journal-title":"Cell Res"},{"issue":"12","key":"3485_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375. https:\/\/doi.org\/10.1038\/nrc3380. (From NLM Medline).","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3485_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0. (From NLM Medline).","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3485_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","volume":"26","author":"T Nakamura","year":"2024","unstructured":"Nakamura T, Conrad M. Exploiting ferroptosis vulnerabilities in cancer. Nat Cell Biol. 2024;26(9):1407\u201319. https:\/\/doi.org\/10.1038\/s41556-024-01425-8. (From NLM Medline).","journal-title":"Nat Cell Biol"},{"issue":"7","key":"3485_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405\u201314. https:\/\/doi.org\/10.1038\/s41568-019-0149-1.","journal-title":"Nat Rev Cancer"},{"issue":"1\u20132","key":"3485_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010. (From NLM Medline).","journal-title":"Cell"},{"issue":"10","key":"3485_CR13","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1039\/d0cs00718h","volume":"50","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev. 2021;50(10):6013\u201341. https:\/\/doi.org\/10.1039\/d0cs00718h. (From NLM Medline).","journal-title":"Chem Soc Rev"},{"issue":"47","key":"3485_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004853","volume":"32","author":"L Rao","year":"2020","unstructured":"Rao L, Zhao SK, Wen C, Tian R, Lin L, Cai B, Sun Y, Kang F, Yang Z, He L, et al. Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles. Adv Mater. 2020;32(47): e2004853. https:\/\/doi.org\/10.1002\/adma.202004853. (From NLM Medline).","journal-title":"Adv Mater"},{"key":"3485_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201808200","author":"H Min","year":"2019","unstructured":"Min H, Wang J, Qi Y, Zhang Y, Han X, Xu Y, Xu J, Li Y, Chen L, Cheng K, et al. Biomimetic metal-organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy. Adv Mater. 2019. https:\/\/doi.org\/10.1002\/adma.201808200.","journal-title":"Adv Mater"},{"issue":"47","key":"3485_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202003214","volume":"32","author":"S Liang","year":"2020","unstructured":"Liang S, Deng X, Ma P, Cheng Z, Lin J. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy. Adv Mater. 2020;32(47): e2003214. https:\/\/doi.org\/10.1002\/adma.202003214. (From NLM Medline).","journal-title":"Adv Mater"},{"issue":"23","key":"3485_CR17","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1039\/d0cc07750j","volume":"57","author":"W Um","year":"2021","unstructured":"Um W, EK PK, Lee J, Kim CH, You DG, Park JH. Recent advances in nanomaterial-based augmented sonodynamic therapy of cancer. Chem Commun. 2021;57(23):2854\u201366. https:\/\/doi.org\/10.1039\/d0cc07750j.","journal-title":"Chem Commun"},{"issue":"9","key":"3485_CR18","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1039\/d1ma00969a","volume":"3","author":"A Tarighatnia","year":"2022","unstructured":"Tarighatnia A, Fouladi MR, Nader ND, Aghanejad A, Ghadiri H. Recent trends of contrast agents in ultrasound imaging: a review of the classifications and applications. Mater Adv. 2022;3(9):3726\u201341. https:\/\/doi.org\/10.1039\/d1ma00969a.","journal-title":"Mater Adv"},{"key":"3485_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102895","author":"A Tarighatnia","year":"2021","unstructured":"Tarighatnia A, Fouladi MR, Tohidkia MR, Johal G, Nader ND, Aghanejad A, Ghadiri H. Engineering and quantification of bismuth nanoparticles as targeted contrast agent for computed tomography imaging in cellular and animal models. J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2021.102895.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"20","key":"3485_CR20","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1039\/d1tb00407g","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Niu C. IR780-based nanomaterials for cancer imaging and therapy. J Mater Chem B. 2021;9(20):4079\u201397. https:\/\/doi.org\/10.1039\/d1tb00407g. (From NLM Medline).","journal-title":"J Mater Chem B"},{"key":"3485_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122456","volume":"305","author":"S Chen","year":"2024","unstructured":"Chen S, Ma T, Wang J, Liang S, Liao H, Tan W, Chen M, Zhou X, Xu Y, Wang L, et al. Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis. Biomaterials. 2024;305: 122456. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122456. (From NLM Medline).","journal-title":"Biomaterials"},{"issue":"5","key":"3485_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRPalpha immune checkpoint. Immunity. 2020;52(5):742\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.011. (From NLM Medline).","journal-title":"Immunity"},{"issue":"2","key":"3485_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-021-01625-x","volume":"28","author":"J Theruvath","year":"2022","unstructured":"Theruvath J, Menard M, Smith BAH, Linde MH, Coles GL, Dalton GN, Wu W, Kiru L, Delaidelli A, Sotillo E, et al. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nat Med. 2022;28(2):333\u201344. https:\/\/doi.org\/10.1038\/s41591-021-01625-x. (From NLM Medline).","journal-title":"Nat Med"},{"key":"3485_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026849118","author":"R Upton","year":"2021","unstructured":"Upton R, Banuelos A, Feng D, Biswas T, Kao K, McKenna K, Willingham S, Ho PY, Rosental B, Tal MC, et al. Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance. Proc Natl Acad Sci USA. 2021. https:\/\/doi.org\/10.1073\/pnas.2026849118. (From NLM Medline).","journal-title":"Proc Natl Acad Sci USA"},{"key":"3485_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000905","author":"H Wang","year":"2020","unstructured":"Wang H, Sun Y, Zhou X, Chen C, Jiao L, Li W, Gou S, Li Y, Du J, Chen G, et al. CD47\/SIRPalpha blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2020-000905. (From NLM Medline).","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3485_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20(1):33\u201348. https:\/\/doi.org\/10.1038\/s41571-022-00699-x. (From NLM Medline).","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"3485_CR27","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1021\/acs.nanolett.0c01503","volume":"20","author":"X Xie","year":"2020","unstructured":"Xie X, Hu X, Li Q, Yin M, Song H, Hu J, Wang L, Fan C, Chen N. Unraveling cell-type-specific targeted delivery of membrane-camouflaged nanoparticles with plasmonic imaging. Nano Lett. 2020;20(7):5228\u201335. https:\/\/doi.org\/10.1021\/acs.nanolett.0c01503. (From NLM Medline).","journal-title":"Nano Lett"},{"issue":"12","key":"3485_CR28","doi-asserted-by":"publisher","first-page":"19756","DOI":"10.1021\/acsnano.1c07180","volume":"15","author":"J Xiong","year":"2021","unstructured":"Xiong J, Wu M, Chen J, Liu Y, Chen Y, Fan G, Liu Y, Cheng J, Wang Z, Wang S, et al. Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer. ACS Nano. 2021;15(12):19756\u201370. https:\/\/doi.org\/10.1021\/acsnano.1c07180. (From NLM Medline).","journal-title":"ACS Nano"},{"issue":"10","key":"3485_CR29","doi-asserted-by":"publisher","first-page":"13894","DOI":"10.1021\/acsnano.0c06290","volume":"14","author":"P Sun","year":"2020","unstructured":"Sun P, Deng Q, Kang L, Sun Y, Ren J, Qu X. A smart nanoparticle-laden and remote-controlled self-destructive macrophage for enhanced chemo\/chemodynamic synergistic therapy. ACS Nano. 2020;14(10):13894\u2013904. https:\/\/doi.org\/10.1021\/acsnano.0c06290. (From NLM Medline).","journal-title":"ACS Nano"},{"issue":"6","key":"3485_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206009","volume":"10","author":"S Zhang","year":"2023","unstructured":"Zhang S, Xia S, Chen L, Chen Y, Zhou J. Covalent organic framework nanobowls as activatable nanosensitizers for tumor-specific and ferroptosis-augmented sonodynamic therapy. Adv Sci (Weinh). 2023;10(6): e2206009. https:\/\/doi.org\/10.1002\/advs.202206009. (From NLM Medline).","journal-title":"Adv Sci (Weinh)"},{"issue":"23","key":"3485_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402516","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Niu X, Ding C, Lin Y, Fang W, Yan L, Cheng J, Zou J, Tian Y, Huang W, et al. Carrier-free self-assembly nano-sonosensitizers for sonodynamic-amplified cuproptosis-ferroptosis in glioblastoma therapy. Adv Sci (Weinh). 2024;11(23): e2402516. https:\/\/doi.org\/10.1002\/advs.202402516. (From NLM Medline).","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3485_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1021\/acsnano.1c08585","volume":"16","author":"Y Xu","year":"2022","unstructured":"Xu Y, Guo Y, Zhang C, Zhan M, Jia L, Song S, Jiang C, Shen M, Shi X. Fibronectin-coated metal-phenolic networks for cooperative tumor chemo-\/chemodynamic\/immune therapy via enhanced ferroptosis-mediated immunogenic cell death. ACS Nano. 2022;16(1):984\u201396. https:\/\/doi.org\/10.1021\/acsnano.1c08585. (From NLM Medline).","journal-title":"ACS Nano"},{"key":"3485_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"F Ursini","year":"2020","unstructured":"Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175\u201385. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.027. (From NLM Medline).","journal-title":"Free Radic Biol Med"},{"issue":"25","key":"3485_CR34","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1021\/jacs.9b03457","volume":"141","author":"LS Lin","year":"2019","unstructured":"Lin LS, Huang T, Song J, Ou XY, Wang Z, Deng H, Tian R, Liu Y, Wang JF, Liu Y, et al. Synthesis of copper peroxide nanodots for H(2)O(2) self-supplying chemodynamic therapy. J Am Chem Soc. 2019;141(25):9937\u201345. https:\/\/doi.org\/10.1021\/jacs.9b03457. (From NLM Medline).","journal-title":"J Am Chem Soc"},{"issue":"5","key":"3485_CR35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042. (From NLM Medline).","journal-title":"Cell"},{"issue":"5","key":"3485_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350. https:\/\/doi.org\/10.1038\/s41591-018-0014-x. (From NLM Medline).","journal-title":"Nat Med"},{"issue":"11","key":"3485_CR37","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1021\/acs.nanolett.8b03568","volume":"18","author":"C Shi","year":"2018","unstructured":"Shi C, Liu T, Guo Z, Zhuang R, Zhang X, Chen X. Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration. Nano Lett. 2018;18(11):7330\u201342. https:\/\/doi.org\/10.1021\/acs.nanolett.8b03568. (From NLM Medline).","journal-title":"Nano Lett"},{"key":"3485_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau6584","author":"D Wang","year":"2019","unstructured":"Wang D, Wang T, Yu H, Feng B, Zhou L, Zhou F, Hou B, Zhang H, Luo M, Li Y. Engineering nanoparticles to locally activate T cells in the tumor microenvironment. Sci Immunol. 2019. https:\/\/doi.org\/10.1126\/sciimmunol.aau6584. (From NLM Medline).","journal-title":"Sci Immunol"},{"issue":"12","key":"3485_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100149","volume":"10","author":"Z Song","year":"2021","unstructured":"Song Z, Luo W, Zheng H, Zeng Y, Wang J, Chen T. Translational nanotherapeutics reprograms immune microenvironment in malignant pleural effusion of lung adenocarcinoma. Adv Healthc Mater. 2021;10(12): e2100149. https:\/\/doi.org\/10.1002\/adhm.202100149. (From NLM Medline).","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"3485_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression\u2014implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16(6):356\u201371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7. (From NLM Medline).","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3485_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49\u201361. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010. (From NLM Medline).","journal-title":"Immunity"},{"issue":"2","key":"3485_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41577-022-00737-w","volume":"23","author":"S Goswami","year":"2023","unstructured":"Goswami S, Anandhan S, Raychaudhuri D, Sharma P. Myeloid cell-targeted therapies for solid tumours. Nat Rev Immunol. 2023;23(2):106\u201320. https:\/\/doi.org\/10.1038\/s41577-022-00737-w. (From NLM Medline).","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03485-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03485-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03485-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T07:50:44Z","timestamp":1749455444000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03485-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03485-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}